AbbVie: Acne Vulgaris trials

The registry lists 14 Acne Vulgaris studies with AbbVie as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 4Phase 2 1Phase 3 1Phase 4 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Dapsone Gel in Females With Skin of Color and Acne VulgarisCompletedNCT02032407Phase 4Results posted
• Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne VulgarisCompletedNCT01773122Phase 1Results posted
• A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum ProductionCompletedNCT01686841Not applicableResults posted
• A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial AcneCompletedNCT01231334Phase 4Results posted
• Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne VulgarisCompletedNCT00835198Phase 4Results posted
• Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne VulgarisCompletedNCT00834210Phase 4Results posted
• Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne VulgarisTerminatedNCT00829049Phase 4Results posted
• Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline HyclateCompletedNCT00635609Phase 4Results posted
• Treatment of Moderate to Severe Facial Acne VulgarisCompletedNCT00612573Phase 2Results posted
• Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne VulgarisCompletedNCT02218034Phase 1
• An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne VulgarisWithdrawnNCT01785836Phase 1
• Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in AcneWithdrawnNCT01425320Phase 1
• Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD DeficiencyCompletedNCT00243542Phase 4
• A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%CompletedNCT00151541Phase 3